Logo image of CIO.CA

CENTRAL IRON ORE LTD (CIO.CA) Stock Fundamental Analysis

TSX-V:CIO - TSX Venture Exchange - AU0000224743 - Common Stock - Currency: CAD

0.075  -0.01 (-16.67%)

Fundamental Rating

0

We assign a fundamental rating of 0 out of 10 to CIO. CIO was compared to 818 industry peers in the Metals & Mining industry. Both the profitability and financial health of CIO have multiple concerns. CIO is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

1

1. Profitability

1.1 Basic Checks

In the past year CIO has reported negative net income.
CIO had a negative operating cash flow in the past year.
CIO.CA Yearly Net Income VS EBIT VS OCF VS FCFCIO.CA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2022 2023 2024 0 500K -500K

1.2 Ratios

With a Return On Assets value of -13.73%, CIO perfoms like the industry average, outperforming 53.91% of the companies in the same industry.
CIO has a Return On Equity (-47.00%) which is comparable to the rest of the industry.
Industry RankSector Rank
ROA -13.73%
ROE -47%
ROIC N/A
ROA(3y)-1.84%
ROA(5y)N/A
ROE(3y)-17.06%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
CIO.CA Yearly ROA, ROE, ROICCIO.CA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2022 2023 2024 0 20 -20 -40

1.3 Margins

The Profit Margin and Operating Margin and Gross Margin are not available for CIO so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
CIO.CA Yearly Profit, Operating, Gross MarginsCIO.CA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2022 2023 2024 0 -500 -1K -1.5K

0

2. Health

2.1 Basic Checks

CIO does not have a ROIC to compare to the WACC, probably because it is not profitable.
CIO has about the same amout of shares outstanding than it did 1 year ago.
The debt/assets ratio for CIO is higher compared to a year ago.
CIO.CA Yearly Shares OutstandingCIO.CA Yearly Shares OutstandingYearly Shares Outstanding 2022 2023 2024 5M 10M 15M 20M
CIO.CA Yearly Total Debt VS Total AssetsCIO.CA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2022 2023 2024 1M 2M 3M 4M

2.2 Solvency

CIO has an Altman-Z score of -6.84. This is a bad value and indicates that CIO is not financially healthy and even has some risk of bankruptcy.
The Altman-Z score of CIO (-6.84) is worse than 67.73% of its industry peers.
CIO has a Debt/Equity ratio of 2.44. This is a high value indicating a heavy dependency on external financing.
CIO has a worse Debt to Equity ratio (2.44) than 76.28% of its industry peers.
Industry RankSector Rank
Debt/Equity 2.44
Debt/FCF N/A
Altman-Z -6.84
ROIC/WACCN/A
WACC8.96%
CIO.CA Yearly LT Debt VS Equity VS FCFCIO.CA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2022 2023 2024 0 1M 2M

2.3 Liquidity

A Current Ratio of 0.11 indicates that CIO may have some problems paying its short term obligations.
CIO has a Current ratio of 0.11. This is amonst the worse of the industry: CIO underperforms 81.05% of its industry peers.
A Quick Ratio of 0.11 indicates that CIO may have some problems paying its short term obligations.
CIO's Quick ratio of 0.11 is on the low side compared to the rest of the industry. CIO is outperformed by 80.68% of its industry peers.
Industry RankSector Rank
Current Ratio 0.11
Quick Ratio 0.11
CIO.CA Yearly Current Assets VS Current LiabilitesCIO.CA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2022 2023 2024 100K 200K 300K 400K 500K

0

3. Growth

3.1 Past

The Earnings Per Share has been growing slightly by 4.71% over the past year.
The Revenue for CIO has decreased by -35.77% in the past year. This is quite bad
EPS 1Y (TTM)4.71%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%46.53%
Revenue 1Y (TTM)-35.77%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%-62.95%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
CIO.CA Yearly Revenue VS EstimatesCIO.CA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2022 2023 2024 200K 400K 600K 800K 1M

0

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for CIO. In the last year negative earnings were reported.
Industry RankSector Rank
PE N/A
Fwd PE N/A
CIO.CA Price Earnings VS Forward Price EarningsCIO.CA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
CIO.CA Per share dataCIO.CA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.02 -0.02

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

No dividends for CIO!.
Industry RankSector Rank
Dividend Yield N/A

CENTRAL IRON ORE LTD

TSX-V:CIO (5/9/2025, 7:00:00 PM)

0.075

-0.01 (-16.67%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryMetals & Mining
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst OwnersN/A
Inst Owner ChangeN/A
Ins Owners10%
Ins Owner ChangeN/A
Market Cap2.80M
Analysts0
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 71.45
P/FCF N/A
P/OCF N/A
P/B 2.15
P/tB 2.15
EV/EBITDA N/A
EPS(TTM)-0.03
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-0.03
FCFYN/A
OCF(TTM)-0.01
OCFYN/A
SpS0
BVpS0.03
TBVpS0.03
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -13.73%
ROE -47%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-1.84%
ROA(5y)N/A
ROE(3y)-17.06%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score3
Asset Turnover0.01
Health
Industry RankSector Rank
Debt/Equity 2.44
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales 1008.18%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.11
Quick Ratio 0.11
Altman-Z -6.84
F-Score3
WACC8.96%
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)4.71%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%46.53%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-35.77%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%-62.95%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-17.3%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1YN/A
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1YN/A
OCF growth 3YN/A
OCF growth 5YN/A